Anew Labs
An AI drug-discovery company that combines molecular models, experimental biology and a drug pipeline to identify and develop new medicines.
$290MFunding
LeadGV
GL Ventures
Activity from announced rounds
Activity in this selectiontrue-equity-ebb89d19
- Rounds participated in
- 6
- Confirmed lead rounds
- 1 4 roles undisclosed
- New companies
- 6 First participation on record · 0 follow-on
- Funding in participating rounds
- $623M 6 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
6 in this selectionClipto
Clipto builds AI tools for searching and working with video and audio libraries.
$15MFunding
ParticipantLTZ Therapeutics
Develops immunotherapies to harness myeloid biology for cancer treatment
$38MUndisclosed
Role not disclosedSyneron Bio
Develops intelligent platform-driven macrocyclic peptide drug discovery
$150MSeries B
Role not disclosedDify
Helps teams build deploy and operate production-grade AI applications and agentic workflows
$30MPre-Series A
Role not disclosedEPG
Provides modular and prefabricated data center infrastructure
$100MSeries B
Role not disclosed